LSL Pharma Group Faces Financial Challenges Amid Valuation Adjustment and Loss-Making Status
LSL Pharma Group, Inc. has recently experienced a valuation adjustment reflecting changes in its financial metrics. The company is currently loss-making, with key indicators such as a non-applicable P/E ratio and negative returns on capital and equity, highlighting its challenging market position within the Gems, Jewellery and Watches industry.
LSL Pharma Group, Inc., operating within the Gems, Jewellery and Watches industry, has recently undergone an evaluation adjustment that reflects changes in its financial metrics. The company’s valuation score has been revised, indicating a shift in its market position. Key financial indicators reveal that LSL Pharma Group, Inc. is currently loss-making, as evidenced by its P/E ratio being classified as not applicable. The Price to Book Value stands at 1.96, while the EV to EBIT and EV to EBITDA ratios are reported at -12.43 and -17.13, respectively. Additionally, the EV to Capital Employed ratio is noted at 1.62, and the EV to Sales ratio is 5.10.
The latest Return on Capital Employed (ROCE) is recorded at -12.99%, and the Return on Equity (ROE) is at -28.83%. These metrics provide a comprehensive view of the company's current financial landscape and its standing within the industry.
For more insights into LSL Pharma Group, Inc. and its financial trend performance, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Most Read
